Evaluation of Predicting the Value of the Reticulocyte Hemoglobin Equivalent for Iron Deficiency in Chronic Kidney Disease Patients

Background: Iron management is essential for anemia treatment in chronic kidney disease. The reticulocyte hemoglobin equivalent (RET-He) a parameter that reflects synthesis of newly formed erythrocytes the bone marrow real-time. Objectives: This study aims to evaluate role predicting iron deficiency disease (CKD) patients. Methods: Following descriptive cross-sectional observational design, this was conducted on 131 adult patients with CKD stages 3 - 5. Laboratory indices, including complete blood count, some biochemical status, and indices (including RET-He), were measured. (ID) defined as TSAT < 20%, where serum ferritin level > 100 ng/mL functional ID, while